- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Implication of Phosphodiesterase-4-Inhibition
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages 1209
Publisher
MDPI AG
Online
2022-01-24
DOI
10.3390/ijms23031209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders
- (2021) Sébastien Delhaye et al. MOLECULAR PSYCHIATRY
- Roflumilast Reduced the IL-18-Induced Inflammatory Response in Fibroblast-Like Synoviocytes (FLS)
- (2021) Bing Zhong et al. ACS Omega
- PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
- (2021) Claire Lugnier et al. BIOCHEMICAL PHARMACOLOGY
- The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure
- (2021) Tongbin Gao et al. MEDICINE
- Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
- (2021) Hao Yan et al. BIOMEDICINE & PHARMACOTHERAPY
- PDE4 subtypes in cancer
- (2020) Samuel Hsien Lai et al. ONCOGENE
- Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury
- (2020) Xingkai Xu et al. MEDICAL SCIENCE MONITOR
- Phosphodiesterase 4B: Master Regulator of Brain Signaling
- (2020) Amy J. Tibbo et al. Cells
- Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
- (2020) Mauro Giorgi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trial of Roflumilast Cream for Chronic Plaque Psoriasis
- (2020) Mark G. Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study
- (2020) Maurizio Cutolo et al. RHEUMATOLOGY
- Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate‐salt hypertensive uni‐nephrectomized KKA y mice
- (2020) Yasunori Nio et al. FASEB JOURNAL
- THE PHOSPHODIESTERASE INHIBITOR ENSIFENTRINE REDUCES PRODUCTION OF PRO-INFLAMMATORY MEDIATORS IN WELL-DIFFERENTIATED BRONCHIAL EPITHELIAL CELLS BY INHIBITING PDE4.
- (2020) Mark Turner et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
- (2020) Manar Mohammed El Tabaa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phosphodiesterases as therapeutic targets for respiratory diseases
- (2019) Haoxiao Zuo et al. PHARMACOLOGY & THERAPEUTICS
- Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation
- (2019) Jakob Wollborn et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study
- (2019) Arjan Blokland et al. NEUROBIOLOGY OF AGING
- Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
- (2019) Robert Bissonnette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
- (2019) Mara Massimi et al. Cells
- Efficacy and safety of phosphodiesterase 4 inhibitors in patients with asthma: A systematic review and meta-analysis
- (2018) Jian Luo et al. RESPIROLOGY
- cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia
- (2018) Haitao Wang et al. Frontiers in Molecular Neuroscience
- The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition
- (2018) Emma Guttman‐Yassky et al. EXPERIMENTAL DERMATOLOGY
- Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
- (2018) Heng Li et al. Frontiers in Pharmacology
- Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial
- (2017) Pim R. A. Heckman et al. PSYCHOPHARMACOLOGY
- Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex
- (2016) Peter H. Schafer et al. CELLULAR SIGNALLING
- Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells
- (2016) Nahid Eskandari et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
- (2016) Amy S. Paller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor
- (2016) M Fujita et al. MOLECULAR PSYCHIATRY
- The Popeye domain containing protein family – A novel class of cAMP effectors with important functions in multiple tissues
- (2016) Roland F.R. Schindler et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
- (2015) Melinda Gooderham et al. BIODRUGS
- PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner
- (2015) Michael Lehrke et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma
- (2015) A N Suhasini et al. LEUKEMIA
- Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition
- (2015) Alexander McGirr et al. NEUROPSYCHOPHARMACOLOGY
- The Unrecognized Effects of Phosphodiesterase 4 on Epithelial Cells in Pulmonary Inflammation
- (2015) Franziska M. Konrad et al. PLoS One
- Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation
- (2014) Jakob Theorell et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease
- (2014) Mark A Giembycz et al. CURRENT OPINION IN PHARMACOLOGY
- Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells
- (2014) Tatiana Victoni et al. PLoS One
- PKA Compartmentalization via AKAP220 and AKAP12 Contributes to Endothelial Barrier Regulation
- (2014) Mariya Y. Radeva et al. PLoS One
- Phosphodiesterase 4 Inhibition Dose Dependently Stabilizes Microvascular Barrier Functions and Microcirculation in a Rodent Model of Polymicrobial Sepsis
- (2014) Sven Flemming et al. SHOCK
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Interferon- Suppresses cAMP to Disarm Human Regulatory T Cells
- (2013) N. Bacher et al. CANCER RESEARCH
- cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier— a signaling pathway compromised in inflammation
- (2013) Nicolas Schlegel et al. CELL AND TISSUE RESEARCH
- PDE4 as a target for cognition enhancement
- (2013) Wito Richter et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulation of metabolism by cGMP
- (2013) Alexander Pfeifer et al. PHARMACOLOGY & THERAPEUTICS
- A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
- (2012) Aman Samrao et al. ARCHIVES OF DERMATOLOGY
- Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
- (2012) Peter Schafer BIOCHEMICAL PHARMACOLOGY
- Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia
- (2012) J. J. Yang et al. BLOOD
- Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation
- (2012) Martin Alexander Schick et al. JOURNAL OF PHYSIOLOGY-LONDON
- Distinct PKA and Epac compartmentalization in airway function and plasticity
- (2012) Bart G.J. Dekkers et al. PHARMACOLOGY & THERAPEUTICS
- cAMP regulation of airway smooth muscle function
- (2012) Charlotte K. Billington et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Protective Effects of Phosphodiesterase-4-specific Inhibitor Rolipram on Acute Ischemia-reperfusion Injury in Rat Kidney
- (2012) Emin Mammadov et al. UROLOGY
- Basophil recruitment and activation in inflammatory skin diseases
- (2011) Y. Ito et al. ALLERGY
- Emerging themes of cAMP regulation of the pulmonary endothelial barrier
- (2011) Sarah L. Sayner AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide
- (2011) A Buenestado et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gene Set Enrichment Analysis Unveils the Mechanism for the Phosphodiesterase 4B Control of Glucocorticoid Response in B-cell Lymphoma
- (2011) S.-W. Kim et al. CLINICAL CANCER RESEARCH
- Disease-modifying effect of ASP3258, a novel phosphodiesterase type 4 inhibitor, on subchronic cigarette smoke exposure-induced lung injury in guinea pigs
- (2011) Satoshi Kubo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma
- (2010) S.-L. Catherine Jin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER
- (2010) Amanda G. Vang et al. PLoS One
- Comorbidities in Patients with Psoriasis
- (2009) Alice B. Gottlieb et al. AMERICAN JOURNAL OF MEDICINE
- Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells
- (2009) Hongli Dong et al. BIOCHEMICAL PHARMACOLOGY
- Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro*
- (2009) Nicolas Schlegel et al. CRITICAL CARE MEDICINE
- Asthma and chronic obstructive pulmonary disease
- (2009) Stefano Guerra Current Opinion in Allergy and Clinical Immunology
- Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
- (2009) Han-Ting Zhang CURRENT PHARMACEUTICAL DESIGN
- Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases
- (2009) George S. Baillie FEBS Journal
- Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model
- (2009) Ya-juan Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chronic Lymphocytic Leukemia and B and T Cells Differ in Their Response to Cyclic Nucleotide Phosphodiesterase Inhibitors
- (2009) J. A. Meyers et al. JOURNAL OF IMMUNOLOGY
- Cyclic AMP
- (2008) Carlos H. Serezani et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The Pathology of Chronic Obstructive Pulmonary Disease
- (2008) James C. Hogg et al. Annual Review of Pathology-Mechanisms of Disease
- Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change
- (2008) Kirsty F. Mackenzie et al. BIOCHEMICAL JOURNAL
- Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
- (2008) P. Goldhoff et al. CLINICAL CANCER RESEARCH
- An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast
- (2008) A. B. Gottlieb et al. CURRENT MEDICAL RESEARCH AND OPINION
- Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
- (2008) H. Meurs et al. EUROPEAN RESPIRATORY JOURNAL
- Preventive Effect of Rolipram, a Phosphodiesterase 4 Enzyme Inhibitor, on Oxidative Renal Injury in Acute Ascending Pyelonephritis Model in Rats
- (2008) Sadık Görür et al. UROLOGY
- Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
- (2008) Piero A Martorana et al. BMC Pulmonary Medicine
- Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease
- (2007) Thais Mauad et al. CURRENT OPINION IN PULMONARY MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now